Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apollo Endosurgery to Participate in Upcoming Investor Conferences By: ACCESSWIRE November 07, 2022 at 09:00 AM EST AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that its senior management team will host investor meetings at four investor conference events during November and December 2022. Event: Stifel 2022 Healthcare ConferenceDate: Wednesday, November 16, 2022Presentation: 2:25 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York CityWebcast: www.apolloendo.com Event: 13th Annual Craig-Hallum Alpha Select ConferenceDate: Thursday, November 17, 2022Presentation: 1x1 meetings availableLocation: Sheraton New York Times Square Hotel, New York City Event: Piper Sandler 34th Annual Healthcare ConferenceDate: Wednesday, November 30, 2022Presentation: 4:00 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York City Event: Stifel Medtech Madness West Coast Bus TourDate: Wednesday, December 14, 2022Presentation: 4:45 p.m. Pacific TimeLocation: Rosewood Sand Hill Hotel, Menlo Park, CA For more information about scheduling a one-on-one meeting with management, please contact your institutional sales representative at the respective conference host or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com. About Apollo Endosurgery, Inc. Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, minimally invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications, and weight loss as a treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch® Endoscopic Suturing System, the OverStitch SxTM Endoscopic Suturing System, X-Tack® Endoscopic HeliX Tacking System, the ORBERA® Intragastric Balloon, X-Tack® Endoscopic HeliX Tacking System, as well as the Apollo ESGTM, Apollo ESG SxTM, Apollo REVISETM and Apollo REVISE SxTM Systems. Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com. Contact: Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.com Darrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.com SOURCE: Apollo Endosurgery, Inc. View source version on accesswire.com: https://www.accesswire.com/724154/Apollo-Endosurgery-to-Participate-in-Upcoming-Investor-Conferences Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Apollo Endosurgery to Participate in Upcoming Investor Conferences By: ACCESSWIRE November 07, 2022 at 09:00 AM EST AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that its senior management team will host investor meetings at four investor conference events during November and December 2022. Event: Stifel 2022 Healthcare ConferenceDate: Wednesday, November 16, 2022Presentation: 2:25 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York CityWebcast: www.apolloendo.com Event: 13th Annual Craig-Hallum Alpha Select ConferenceDate: Thursday, November 17, 2022Presentation: 1x1 meetings availableLocation: Sheraton New York Times Square Hotel, New York City Event: Piper Sandler 34th Annual Healthcare ConferenceDate: Wednesday, November 30, 2022Presentation: 4:00 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York City Event: Stifel Medtech Madness West Coast Bus TourDate: Wednesday, December 14, 2022Presentation: 4:45 p.m. Pacific TimeLocation: Rosewood Sand Hill Hotel, Menlo Park, CA For more information about scheduling a one-on-one meeting with management, please contact your institutional sales representative at the respective conference host or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com. About Apollo Endosurgery, Inc. Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, minimally invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications, and weight loss as a treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch® Endoscopic Suturing System, the OverStitch SxTM Endoscopic Suturing System, X-Tack® Endoscopic HeliX Tacking System, the ORBERA® Intragastric Balloon, X-Tack® Endoscopic HeliX Tacking System, as well as the Apollo ESGTM, Apollo ESG SxTM, Apollo REVISETM and Apollo REVISE SxTM Systems. Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com. Contact: Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.com Darrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.com SOURCE: Apollo Endosurgery, Inc. View source version on accesswire.com: https://www.accesswire.com/724154/Apollo-Endosurgery-to-Participate-in-Upcoming-Investor-Conferences
AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that its senior management team will host investor meetings at four investor conference events during November and December 2022. Event: Stifel 2022 Healthcare ConferenceDate: Wednesday, November 16, 2022Presentation: 2:25 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York CityWebcast: www.apolloendo.com Event: 13th Annual Craig-Hallum Alpha Select ConferenceDate: Thursday, November 17, 2022Presentation: 1x1 meetings availableLocation: Sheraton New York Times Square Hotel, New York City Event: Piper Sandler 34th Annual Healthcare ConferenceDate: Wednesday, November 30, 2022Presentation: 4:00 p.m. Eastern Time; 1x1 meetings availableLocation: Lotte New York Palace Hotel, New York City Event: Stifel Medtech Madness West Coast Bus TourDate: Wednesday, December 14, 2022Presentation: 4:45 p.m. Pacific TimeLocation: Rosewood Sand Hill Hotel, Menlo Park, CA For more information about scheduling a one-on-one meeting with management, please contact your institutional sales representative at the respective conference host or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com. About Apollo Endosurgery, Inc. Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, minimally invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications, and weight loss as a treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch® Endoscopic Suturing System, the OverStitch SxTM Endoscopic Suturing System, X-Tack® Endoscopic HeliX Tacking System, the ORBERA® Intragastric Balloon, X-Tack® Endoscopic HeliX Tacking System, as well as the Apollo ESGTM, Apollo ESG SxTM, Apollo REVISETM and Apollo REVISE SxTM Systems. Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com. Contact: Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.com Darrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.com SOURCE: Apollo Endosurgery, Inc. View source version on accesswire.com: https://www.accesswire.com/724154/Apollo-Endosurgery-to-Participate-in-Upcoming-Investor-Conferences